Sovran Advisors’s Colgate-Palmolive CL Stock Holding History

Sovran Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$266K	Sell	2,869 -2	-0.1%	-$175	0.02%	516
2026 Q1	$245K	Buy	2,871 +35	+1%	+$3.12K	0.02%	502
2025 Q4	$239K	Buy	+2,836	New	+$222K	0.02%	493

Other funds holding CL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Sovran Advisors's CL Position: Q2 2026 in Review

Sovran Advisors reduced its Colgate-Palmolive (CL) stake by 0.07% in Q2 2026, selling an estimated $175 and leaving 2,869 shares worth $266K. The position accounts for 0.02% of the portfolio, ranked #516.

Sovran Advisors first reported a position in CL in Q4 2025 and has held it in 3 quarters since. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Sovran Advisors held 2,869 shares of Colgate-Palmolive worth $266K as of Q2 2026.
Sovran Advisors sold 2 Colgate-Palmolive shares in Q2 2026, an estimated $175.
Colgate-Palmolive made up 0.02% of Sovran Advisors's portfolio in Q2 2026, its #516 holding.
Sovran Advisors first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 3 quarters since.
2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Sovran Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.